脂肪酸結合蛋白 4(FABP4)活性蛋白
Active Fatty Acid Binding Protein 4 (FABP4)
A-FABP; AFABP; AP2; Fatty Acid Binding Protein 4, Adipocyte; Adipocyte Protein 2; Adipocyte-type fatty acid-binding protein
- 編號APB693Hu61
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點6.8
- 應用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1296 ¥ 3240 ¥ 6480 ¥ 19440 ¥ 48600
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
活性實驗
Fatty acid binding protein-4 (FABP4) is a member of a large superfamily of lipid binding proteins that are expressed in a tissue specific manner. FABP4 is one of ten cytoplasmic FABPs that are 14-15 kDa in size and range from 126-140 amino acids (aa) in length. Although all are highly conserved in their tertiary structure, there is only modest aa identity between any two members. Lipase, Hormone Sensitive (LIPE) has been identified as an interactor of FABP4, thus a binding ELISA assay was conducted to detect the interaction of recombinant human FABP4 and recombinant human LIPE. Briefly, FABP4 were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 ul were then transferred to LIPE-coated microtiter wells and incubated for 1h at 37℃. Wells were aspirated and incubated for 1h with anti-FABP4 mAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 5 times. With the addition of substrate solution , wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450 nm immediately. The binding activity of FABP4 and LIPE was shown in Figure 1, and this effect was in a dose dependent manner. The EC50?for this effect is 4.23 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
EPB693Hu61 | 脂肪酸結合蛋白 4(FABP4)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPB693Hu62 | 脂肪酸結合蛋白 4(FABP4)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB693Hu01 | 脂肪酸結合蛋白 4(FABP4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB693Hu61 | 脂肪酸結合蛋白 4(FABP4)活性蛋白 | Cell?culture;?Activity?Assays. |
PAB693Hu06 | 脂肪酸結合蛋白 4(FABP4)多克隆抗體 | WB; IHC; ICC; IP. |
PAB693Hu01 | 脂肪酸結合蛋白 4(FABP4)多克隆抗體 | WB; IHC; ICC; IP. |
FAB693Hu01 | 抗脂肪酸結合蛋白 4(FABP4)多克隆抗體 | Flow cytometry. |
LAB693Hu71 | 脂肪酸結合蛋白 4(FABP4)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAB693Hu21 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
MAB693Hu23 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
MAB693Hu24 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
MAB693Hu25 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
MAB693Hu27 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
MAB693Hu29 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
MAB693Hu22 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC. |
FAB693Hu02 | 抗脂肪酸結合蛋白 4(FABP4)單克隆抗體 | Flow cytometry. |
FAB693Hu06 | 抗脂肪酸結合蛋白 4(FABP4)單克隆抗體 | Flow cytometry. |
FAB693Hu04 | 抗脂肪酸結合蛋白 4(FABP4)單克隆抗體 | FCM |
SEB693Hu | 脂肪酸結合蛋白 4(FABP4)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB693Hu | 脂肪酸結合蛋白 4(FABP4)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Clinical and Molecular Hepatology | Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH [PubMed: 23091808] |
journal of Human Hypertension | Siesta is associated with reduced systolic blood pressure level and decreased prevalence of hypertension in older adults [PubMed: 26134622] |
genetics and molecular research | Overexpression of the A-FABP gene facilitates intermuscular fat deposition in transgenic mice [PubMed: 25867423] |
Food Chem | Cranberries (Oxycoccus quadripetalus) inhibit lipid metabolism and modulate leptin and adiponectin secretion in 3T3-L1 adipocytes [PubMed: 25952883] |
Placenta | Increased expression of fatty acid binding protein 4 in preeclamptic Placenta and its relevance to preeclampsia [Pubmed:26992681] |
Clin Chim Acta. | Valproate acid (VPA)-induced dysmetabolic function in clinical and animal studies. [pubmed:28161274] |
Oxidative?Medicine?and?Cellular?Longevity | Changes of Plasma FABP4, CRP, Leptin, and Chemerin Levels in relation to Different Dietary Patterns and Duodenal-Jejunal Omega Switch Surgery in Sprague?… [Pubmed:29849871] |
Nutrition &?Diabetes | Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans [Pubmed:29335416] |
American Journal of Cancer Research | 25-HC promotes hepatocellular carcinoma metastasis through up-regulation of TLR4 dependent FABP4 [Pubmed: 31720079] |
J Magn Reson Imaging | Water Specific MRI T1 Mapping for Evaluating Liver Inflammation Activity Grades in Rats With Methionine‐Choline‐Deficient Diet‐Induced Nonalcoholic Fatty Liver?… [Pubmed:35212074] |
cells | The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure [Pubmed:35455943] |
Bone Research | FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis [Pubmed:35729106] |